Acumen Pharmaceuticals Bolsa (NASDAQ: ABOS)

Acumen Pharmaceuticals (NASDAQ:ABOS) Bolsa

Acumen Pharmaceuticals

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals Inc

Economist Jeffrey Sachs compared President Donald Trump&#8217;s tariff logic to blaming shopkeepers for a maxed-out credit card.
What Happened: Arguing at Turkey's Antalya Diplomacy Forum, Sachs said, &#8220;If you take your credit card and you go shopping and you run up a large credit card debt, you're running a trade deficit with all those shops. Now, it would be pretty strange if you then blamed all the shop owners for having sold you all those things.&#8221;
Sachs added that the United States "is outspending its national income," not being "cheated" by trading partners. The Columbia professor's quip lands as Trump's new duties, some as high as 145 percent, roil markets and stoke fears of higher consumer prices.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Jeffrey Sachs on tariffs: &quot;If you take your credit card and you go shopping and you run up a large credit card debt, you're running a trade deficit with all those shops. Now, it would be pretty strange if you then blamed all the shop owners for having sold you all those things.&quot; <a href="https://t.co/Qrar2pIsNt">pic.twitter.com/Qrar2pIsNt</a>
&mdash; unusual_whales (@unusual_whales) <a href="https://twitter.com/unusual_whales/status/1916583378088001715?ref_src=twsrc%5Etfw">April 27, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See also: <a href="https://www.benzinga.com/markets/equities/25/04/45058829/jim-cramer-dismisses-recession-panic-says-tariffs-may-sting-but-too-many-jobs-for-economy-to-derail">Jim Cramer Dismisses Recession Panic: Says Tariffs May Sting, But Too &#8216;Many Jobs&#8217; For Economy To &#8216;Derail&#8217;</a>
Sachs told delegates that a trade deficit reflects domestic overspending, not foreign perfidy: "It would be pretty strange if you blamed all the shop owners for having sold you things." He mocked Trump's grasp of macroeconomics, saying the former president "never made it to the second day" of an international-finance course where such identities are taught.
Why It Matters: Investors are already bracing for sticker shock as tariffs bite. Surveys this week found that a majority of <a href="https://www.benzinga.com/markets/equities/25/04/45027881/trumps-approval-plummets-as-tariffs-bite-americans-expect-skyrocketing-prices-and-shrinking-wallets">Americans expect prices</a> to "skyrocket" if Trump's trade war deepens.​ That said, analysts note the White House has twice eased duties after spikes in Treasury yields signaled market stress.​ Cathie Wood likewise called the levies "tax increases that hurt growth," though she <a href="https://www.benzinga.com/markets/25/04/45000154/cathie-wood-warns-trumps-tariffs-are-tax-increases-that-hurt-growth-but-says-innovation-will-thrive-in-the-turmoil">predicted</a> Trump ultimately wants all barriers negotiated down.
Factory-floor fallout is spreading: Chinese manufacturers are idling plants and <a href="https://www.benzinga.com/markets/equities/25/04/45032435/trump-tariffs-prompt-suspension-of-chinese-factory-operations-and-shift-to-new-markets">hunting new buyers</a>, while U.S. automakers expect <a href="https://www.benzinga.com/25/04/45059191/donald-trump-will-reduce-impact-on-us-auto-industry-by-alleviating-some-auto-tarrifs-report">partial tariff relief</a> to blunt cost shocks. Meanwhile, recession chatter intensifies as consumer confidence slips and <a href="https://www.benzinga.com/personal-finance/25/04/44611151/recession-fears-surge-what-consumers-and-cfos-expect-how-it-could-impact-bitcoin-and-the-crypto-market">CFOs flag</a> weaker spending momentum.​
Image via Shutterstock
Read next: <a href="https://www.benzinga.com/general/education/25/04/45059231/mark-zuckerberg-says-theres-going-to-have-to-be-a-reckoning-about-college-degrees-and-whether-theyre-truly-worth-it-anymore">Mark Zuckerberg Says &#8216;Reckoning&#8217; For College Degrees Is Nearing As Student Debt Balloons: &#8216;You&#8217;re Starting Off In This Big Hole&#8217;</a>

Government

Regulations

Jeffrey Sachs Compares Trump's Tariff Logic To Maxing A Credit Card And Blaming The Store, Says US Simply 'Outspending Its National Income'

Swedbank (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SWDBY#OTC">SWDBY</a>) reported quarterly earnings of $0.68 per share. This is a 5.56 percent decrease over earnings of $0.72 per share from the same period last year. The company reported $1.62 billion in sales this quarter. This is a 6.78 percent decrease over sales of $1.74 billion the same period last year.

Earnings

News

SWDBY

Swedbank Q1 EPS $0.68 Down From $0.72 YoY, Sales $1.62B Down From $1.74B YoY

ACGL

AEYE

AMSF

APAM

ARCB

ARCC

ASTE

ASTL

ATRC

BBIO

BBVA

BGFV

BKNG

BRSP

CECO

CHCT

CLVT

CSGP

CVLT

DHIL

ENSG

ENVA

ESRT

ETWO

EXLS

FELE

FFIC

FIBK

FICO

FOUR

FRSH

FRST

FSLR

FYBR

HLMN

HOUS

HRZN

HSBC

HURN

ILPT

INCY

INTZ

JAKK

JBGS

JBLU

KNSA

LFUS

LGIH

Laboratory Corporation Of America Holdings

LOGI

LXFR

Earnings Scheduled For April 29, 2025

Tech investor Chamath Palihapitiya highlighted the rising dominance of stablecoins in the global financial system Tuesday, deeming them one of the hottest cryptocurrency narratives besides Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
What Happened: As part of his deep dive into the stablecoin market, Palihapitiya noted that stablecoins&#8217; weekly transaction volumes have exceeded that of Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>).
These findings were corroborated by a recent report by asset management firm Bitwise, which <a href="https://s3.us-east-1.amazonaws.com/static.bitwiseinvestments.com/Research/Bitwise-Crypto-Market-Review-Q1-2025.pdf">showed </a>stablecoin transaction volumes overtaking the payments giant by 2024. In 2020, stablecoin volumes were 11% of total VISA volumes.
The dominance led Palihapitiya to call dollar-backed stablecoins, including Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>) and USD Coin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>), the &#8220;second killer app&#8221; in the cryptocurrency space, next to Bitcoin.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Deep Dive: A Primer on Stablecoins Last year, Visa announced the launch of the Visa Tokenized Asset Platform, a new infrastructure designed to help banks issue and manage stablecoins and tokenized deposits. This week, Stripe began testing a stablecoin pilot, aiming to help… <a href="https://t.co/pYpRcA7hEG">pic.twitter.com/pYpRcA7hEG</a>
&mdash; Chamath Palihapitiya (@chamath) <a href="https://twitter.com/chamath/status/1916970964983972070?ref_src=twsrc%5Etfw">April 28, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Palihapitiya outlined some key developments in the stablecoin market that influenced its growth trajectory. He mentioned Visa&#8217;s&nbsp;launch of the Visa Tokenized&nbsp;Asset Platform, Stripe&#8217;s <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38460707/stripe-makes-a-crypto-comeback-accepts-stablecoins-for-online-payments">stablecoin pilot</a>, and Mastercard&#8217;s&nbsp;new <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44935132/the-quiet-rise-of-the-worlds-new-money-standard">features </a>that allow consumers&nbsp;to spend stablecoins.
See Also:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/04/45058619/arizona-moving-to-convert-up-to-10-of-its-treasury-to-bitcoin-legislature-clears-bills-paving-way-for-strategic-crypto-reserve" target="_blank" rel="noreferrer noopener">Arizona Moving To Convert Up to 10% Of Its Treasury To Bitcoin: Legislature Clears Bills Paving Way For Strategic Crypto Reserve </a>
Why It Matters: The rise of dollar-backed stablecoins has been a hot topic in the cryptocurrency world. According to a&nbsp;multinational bank, Standard Chartered, the <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44812762/stablecoins-to-surge-to-2-trillion-by-2028-says-standard-chartered-heres-what-it-means-for-the-dollar">total value</a> of the stablecoin market is expected to surge from $230 billion today to $2 trillion by the end of 2028, potentially generating $1.6 trillion in additional demand for U.S. Treasury bills.
None other than President Donald Trump has <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44420122/donald-trump-calls-for-stablecoin-legislation-lauds-bitcoin-reserve-biden-got-a-fraction-of-their-value">called on Congress to pass stablecoin legislation</a>, emphasizing the need for clear rules to foster innovation in the cryptocurrency sector. 
The SEC has already stated that stablecoins fully backed by physical U.S. dollars or low-risk, short-term liquid instruments and redeemable at a 1:1 ratio with the U.S. dollar <a href="https://www.benzinga.com/content/44656762/sec-says-certain-stablecoins-qualify-as-non-securities-under-new-guidelines">will be classified as &#8220;non-securities</a>.&#8221;
Price Action: Shares of VISA closed 0.70% higher at $337.51 during Monday&#8217;s regular trading session. The stock exhibited good momentum and quality scores as of this writing. To know more about these metrics and more, check out <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a>.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="505" height="188" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29032855/Screenshot-2025-04-29-125817.png" alt="" class="wp-image-892206" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29032855/Screenshot-2025-04-29-125817.png 505w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29032855/Screenshot-2025-04-29-125817-300x112.png 300w" sizes="(max-width: 505px) 100vw, 505px" /></figure>
Read Next:&nbsp;
<ul>
<li><a href="https://benzinga.com/markets/cryptocurrency/25/04/45039243/xrp-is-the-top-altcoin-bet-10x-research" target="_blank" rel="noreferrer noopener">XRP Is The Top Altcoin Bet: 10x Research</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>
Photo Courtesy: creativeneko on Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

$USDC

$USDT

Chamath Palihapitiya Says Stablecoins Are Crypto's 'Second Killer App' After Bitcoin, As Volumes Surpass Visa

Uber Technologies Inc. is rescinding remote work privileges and making in-office attendance mandatory, following months of other tech giants issuing <a href="https://www.benzinga.com/markets/25/04/44971069/google-to-remote-workers-return-to-office-3-days-a-week-or-take-a-buyout-report">similar directives</a>. The new development was announced internally on Monday and is part of a company-wide push to modify operations under CEO Dara Khosrowshahi.
What Happened: From June, Uber employees will have to work from the office three days a week. Currently, only two days are mandatory. This rule will be applicable for workers who had previously been granted remote status. In a memo viewed <a href="https://www.cnbc.com/2025/04/28/uber-raises-in-office-requirement-to-3-days-claws-back-remote-workers.html">by</a> CNBC, Khosrowshahi said, "I want to emphasize that ‘good' is not going to be good enough — we need to be great." 
Tuesday through Thursday have been designated as mandatory in-office days. The company is also phasing out most new fully remote recruits and reconsidering work-from-home arrangements it had granted earlier.
Uber did not immediately respond to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga</a>'s request for comment.
See Also: <a href="https://www.benzinga.com/news/global/25/04/44877914/from-s-o-paulo-to-sofia-the-emerging-region-hiring-boom-powering-americas-remote-workforce">From São Paulo to Sofia: The Emerging‑Region Hiring Boom Powering America&#8217;s Remote Workforce</a>
Why It Matters: With this move, Uber&#8217;s leadership has underlined its belief that in-person work improves performance. "Being in the office fuels collaboration, sparks creativity, and increases velocity," Khosrowshahi wrote. 
Corporate giants are <a href="https://www.benzinga.com/25/03/44300682/jamie-dimon-doubles-down-on-work-from-home-criticism-where-did-you-get-your-amazon-packages">scaling back flexibility to manage productivity</a> and investor apprehensions after pandemic-era overexpansion. Uber&#8217;s leadership team has said that attendance will be tracked, both at the team and individual levels.
Apart from the RTO move, Uber also changed its eligibility criteria for its one-month paid sabbatical from five to eight years of service. This decision generated speedy internal criticism. "This isn't ‘doing the right thing' for your employees," one staffer posted on the company's Q&amp;A forum, as per CNBC. Khosrowshahi and Chief People Officer Nikki Krishnamurthy are scheduled to address employee doubts and queries concerns at an all-hands meeting on Tuesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/education/25/04/44858177/uber-ceo-dara-khosrowshahi-says-the-two-college-courses-are-absolute-necessity-for-c-suite-aspiring-leaders">Uber CEO Dara Khosrowshahi Says The Two College Courses Are &#8216;Absolute Necessity&#8217; For C-Suite-Aspiring Leaders</a></li>
</ul>
Image Via Shutterstock

Equities

UBER

Uber Orders Employees Back To Office 3 Days A Week: Good 'Is Not Going To Be Good Enough,' Says CEO Dara Khosrowshahi

<ul>
<li>JetCool's SmartSense Coolant Distribution Unit (CDU) liquid-to-liquid solutions support hyperscale, enterprise, and colocation applications</li>
<li>Supported by Flex's advanced manufacturing capabilities and services to enable customers to rapidly scale liquid cooling infrastructure</li>
<li>Flex will highlight the CDU at the 2025 OCP EMEA Summit in booth A18</li>
</ul>

FLEX

Flex Expands JetCool Portfolio With In-Rack SmartSense CDU Delivering Up To 300kW Per Rack

In summary:
<ul>
<li>We urge shareholders not to be misled by the Vivo group's attempts to relitigate an unappealable verdict by the Privy Council, rewrite history, and paint a fictitious picture of the last few years' events, while simultaneously attempting to line their own pockets at your expense.</li>
<li>It is our fiduciary duty to vigorously defend against the hostile actions and lawsuits by the Vivo group so that we may ensure fairness for all shareholders, restore integrity and trust, and position SINOVAC for the future.</li>
<li>We are confident we will prevail, and we want to emphasize that we are urgently working to make things right as soon as possible to mitigate against further chaos and litigation, after what we have all endured over the last seven years.</li>
</ul>

SINOVAC Board Responds To Vivo Capital's Legal Threats, Defends $55/Share Special Dividend For Common Shareholders

General

NTRS

Northern Trust Inks Service Agreement With Ecosystem Certification Organization (ECO) To Provide Recordation And Settlement Services For Digital Carbon Credit Units Issued To Project Developers Under The Natural Forest Standard (NFS)

As part of the carve-out transaction, the management team and all employees currently operating the EMEA colocation business within STACK are expected to migrate with the Company, which will be re-branded and will no longer bear the "STACK Infrastructure" name or logo. STACK will continue its growth trajectory with a focus on hyperscale development and operations across key EMEA markets

Apollo To Acquire Seven-Asset European Colocation Portfolio From STACK Infrastructure In Strategic Carve-Out Transaction

<figure class="table"> 
<table>
<tbody>
<tr>
<td>REAFFIRMING FY25 GUIDANCE[1,4]</td>
</tr>
</tbody>
</table>
</figure>
Outlook for FY25 reflects our current assessment of market conditions. Unless stated otherwise, guidance is on an adjusted comparable[4] &amp; FX-neutral basis.
Revenue: growth of approx.~4%
Balanced between volume &amp; revenue per unit case
Two fewer selling days in Q1, one extra in Q4
Cost of sales per UC: comparable growth of ~2%
Expect broadly flat commodity inflation (hedged at ~90% for FY25)
Concentrate directly linked to revenue per UC through incidence pricing
Operating profit: growth of ~7%
Comparable effective tax rate: ~26%
CAPEX: ~5% of revenue (incl. leases)
Comparable free cash flow: at least €1.7bn
Dividend payout ratio: ~50%[7] based on comparable EPS
Share buyback: €1bn over 12 months from February 2025

Guidance

Coca-Cola European Partners plc Ordinary Shares

CCEP

Coca-Cola Europacific Partners Reaffirms FY25 Outlook With ~4% Revenue Growth, ~7% Profit Increase, 2% Cost Inflation, And €1.7B+ Free Cash Flow

Coca-Cola Europacific Q1 Revenue €4.689B (+5% YoY), Adjusted Comparable Volume -0.8%

The President Donald Trump administration&#8217;s request for Novavax Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) to conduct new clinical trials for its COVID-19 vaccine.
What Happened: Novavax announced Monday that the Food and Drug Administration requested a new clinical trial before granting full approval for its protein-based COVID-19 shot, despite the company believing its vaccine remains &#8220;approvable.&#8221; 
The requirement came shortly after FDA Commissioner Marty Makary characterized the annually updated vaccine as &#8220;a new product&#8221; requiring new studies.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">To be clear, this is a new product that Novavax is trying to introduce to the market with a study of a different product from 2021. New products require new clinical studies. Under this administration, we are prioritizing the Gold Standard of Science&#8211;not what saves pharma… <a href="https://t.co/1f7NvJ9qEJ">pic.twitter.com/1f7NvJ9qEJ</a>
&mdash; Dr. Martin Makary (@DrMakaryFDA) <a href="https://twitter.com/DrMakaryFDA/status/1916253910039429309?ref_src=twsrc%5Etfw">April 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The situation developed following leadership changes at the FDA, including the departure of the agency&#8217;s longtime Vaccine Chief over disagreements with Health Secretary Robert F. Kennedy Jr. 
Industry experts note the FDA had been on track to approve Novavax&#8217;s application by April 1, but Trump appointees directed a pause, the Associated Press <a href="https://apnews.com/article/vaccine-novavax-fda-trump-covid-study-4b4465ad77cfb0554b27b7d59c40ae32">reported</a>, citing anonymous sources.
See Also: <a href="https://www.benzinga.com/general/entertainment/25/04/45059675/mrbeast-sparks-outrage-with-100-men-vs-gorilla-post-on-elon-musks-x-peta-claps-back-try-100-reasons-to-leave-animals">MrBeast Sparks Outrage With &#8216;100 Men Vs Gorilla&#8217; Post On Elon Musk&#8217;s X — PETA Claps Back: &#8216;Try 100 Reasons To Leave Animals&#8230;&#8217;</a>
Why It Matters: A United States Department of Health and Human Services spokesman suggested all COVID-19 vaccines could face stricter requirements, stating: &#8220;The urgency to rush approval of boosters without normal oversight no longer exists.&#8221;
Preliminary results from <a href="https://www.benzinga.com/general/biotech/25/04/44824383/novavax-covid-vaccine-shows-milder-side-effects-than-pfizer-biontechs-shot-study">the SHIELD-Utah study</a> showed Novavax&#8217;s 2024-2025 formula targeting the JN.1 strain produced fewer and less severe side effects compared to Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) and BioNTech SE&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) mRNA shots.
Former Health Secretary Xavier Becerra defended the safety record of COVID-19 vaccines, noting: &#8220;We had put some 700 million COVID vaccines into the arms of Americans. That&#8217;s a pretty good size clinical trial.&#8221;
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/insider-trades/25/04/45059696/airbnb-billionaire-joe-gebbia-buys-over-1-million-worth-of-tsla-stock-ahead-of-elon-musks-robotaxi-launch-in-june">Airbnb Billionaire Joe Gebbia Buys Over $1 Million Worth Of TSLA Stock Ahead Of Elon Musk&#8217;s Robotaxi Launch In June</a></li>
</ul>
Image Via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Health Care

BNTX

MRNA

NVAX

Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline

The Chinese commerce ministry stated that U.S.-imposed tariffs have adversely affected Chinese airlines and Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>). The ministry has called on Washington to consider the grievances of these companies and promote a stable trade environment.
What Happened: This marks Beijing&#8217;s first remark on the tariffs&#8217; impact on the aviation sector since Boeing returned three 737 MAX planes, initially stationed in China for delivery to Chinese customers, back to the U.S,, Reuters reported on Tuesday.
Last week, Boeing disclosed that due to the tariffs, multiple Chinese customers have refused to accept delivery of new planes, leaving the company to find new buyers for potentially dozens of aircraft. Beijing has also signaled concern over the consequences of the trade war.
The ministry underscored China&#8217;s readiness to back normal business collaboration between the two countries and urged&nbsp;Washington to create a predictable&nbsp;trade and investment environment. &#8220;China&#8217;s&nbsp;affected airlines and Boeing have&nbsp;suffered greatly,&#8221; the ministry noted, emphasizing that the U.S. tariffs have&nbsp;disrupted global supply chains, air&nbsp;transport, and investment activities.
SEE ALSO:&nbsp;<a href="https://benzinga.com/25/04/45038824/treasury-secretary-scott-bessent-says-its-up-to-china-to-de-escalate-trade-tensions-india-to-be-the-first-trade-d" target="_blank" rel="noreferrer noopener">Treasury Secretary Scott Bessent Says It&#8217;s Up To China To &#8216;De-Escalate&#8217; Trade Tensions, India To Be The &#8216;First Trade Deal&#8217; To Be Signed</a>
Why It Matters: Beijing recently instructed Chinese airlines to halt new Boeing orders and get approval for pending deliveries, making the company the latest U.S. firm affected by the U.S.-China trade war. 
The U.S. tariffs have led to a significant <a href="https://www.benzinga.com/markets/equities/25/04/45032435/trump-tariffs-prompt-suspension-of-chinese-factory-operations-and-shift-to-new-markets">disruption </a>in the global supply chain. This development has had a ripple effect across global supply chains and threatened millions of jobs. Chinese manufacturers have had to suspend operations and seek alternative markets due to the impact of these tariffs. The country is also at risk of losing nearly 16 million manufacturing jobs amid the escalating trade tensions, as per Goldman Sachs.
Nevertheless, in a bid to ease trade tensions, China has begun <a href="https://www.benzinga.com/news/global/25/04/45004954/china-reportedly-begins-exempting-key-us-imports-from-tariffs-including-pharma-and-aerospace-parts">exempting </a>some U.S. imports from high tariffs. Companies in China have been asked by officials to identify essential U.S. goods that are difficult to replace. Some pharmaceutical imports and aerospace&nbsp;parts, including engines and landing&nbsp;gear, have already been exempted from the 125% tariffs. French aircraft engine maker, Safran confirmed that China granted tariff exemptions on certain aerospace equipment parts, including engines and landing gear.
Boeing closed 2.44% higher on Monday <a href="https://www.benzinga.com/25/04/45047782/boeing-stock-jumps-on-bernstein-upgrade-is-the-company-back-on-track">following </a>Bernstein's upgrade of the stock from a Market Perform to an Outperform rating and an increase in its price target from $181 to $218.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/news/events/25/04/44971154/trump-fails-to-impress-americas-young-shows-poll-as-they-still-favor-biden-only-15-think-us-on-right-track" target="_blank" rel="noreferrer noopener">Trump Fails To Impress America&#8217;s Young, Shows Poll As They Still Favor Biden — Only 15% Think US On Right Track &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Economics

China Breaks Silence On Tariff Impact, Says Trump Policies Are Hurting Its Airlines And Boeing

<ul>
<li>European Commission converts conditional approval of FILSPARI (sparsentan)&nbsp;into standard marketing authorization for the treatment of IgA Nephropathy (IgAN)</li>
<li>Decision follows positive recommendation from Committee for Medicinal Products for Human Use (CHMP) from February 2025</li>
<li>EU approval is based on the complete data set from the phase-III PROTECT study</li>
</ul>

TVTX

Reported Earlier, CSL Vifor And Travere Secure Standard EU Approval For FILSPARI In IgA Nephropathy Following CHMP Recommendation

<ul>
<li>HTWO Energy Savannah will serve Hyundai's new Hyundai Motor Group Metaplant America (HMGMA), utilizing XCIENT hydrogen heavy-duty fuel cell trucks for Clean Logistics</li>
<li>Phase one to create a scalable Class-8 hydrogen refueling solution, in collaboration with HTWO Logistics (Fleet Operations), HydroFleet (Hydrogen Refueling), and Capital Development Partners (Overall Development)</li>
<li>Phase two plans include commercial vehicle electric charging capability</li>
<li>HTWO Energy Savannah marks a significant step forward in the decarbonization of emissions-intensive port operations and major logistics corridors</li>
</ul>

HYMTF

Reported Earlier, Hyundai Announces HTWO Energy Savannah To Power Zero-Emission Heavy-Duty Trucking Near Port Of Savannah

The funds from this operation are intended to be allocated to non-investment expenses, in accordance with the Resolution issued by the MHCP and the company's 2025 financing plan and help reach the Gross Debt/EBITDA target for the year.

Reported Earlier, Ecopetrol Secures Ministry Authorization For $500M Loan Agreement With Banco Santander

Gerdau (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GGB#NYSE">GGB</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.10 by 37 percent. This is a 42.73 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $2.97 billion which beat the analyst consensus estimate of $2.57 billion by 15.45 percent. This is a 9.40 percent decrease over sales of $3.27 billion the same period last year.

Earnings Beats

Earnings Misses

Gerdau Q1 EPS $0.06 Misses $0.10 Estimate, Sales $2.97B Beat $2.57B Estimate

Reported Earlier, Telix Gains French Approval For Illuccix, Expanding Access To PSMA-PET Imaging For Prostate Cancer Diagnosis And Management

TACT

Reported Earlier, TransAct Technologies Powers Digital Transformation With Successful BOHA! Terminal 2 Deployment Across 1,400 Convenience Store Locations

Billionaire Joe Gebbia, co-founder of Airbnb Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>), has purchased over 4000 Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) stocks.
What Happened: Gebbia, who is a member of the company's board of directors, purchased 4000 shares at $256.308, as revealed by an SEC filing on Monday.
Gebbia has been on Tesla's board as an independent director since 2022. He also <a href="https://www.benzinga.com/25/03/44265658/billionaire-airbnb-founder-works-with-elon-musk-at-doge">joined Elon Musk's DOGE</a>, or Department of Government Efficiency, to work on the government's paper-based retirement process.
Why It Matters: The news comes in as Tesla is gearing up for its robotaxi launch in June, which Musk shared at the Q1 earnings call, could feature<a href="https://www.benzinga.com/news/earnings/25/04/44943387/elon-musk-shares-fsd-update-at-tesla-earnings-call-10-to-20-model-ys-will-offer-paid-robotaxi-rides-in-june"> 10 to 20 Model Ys</a> deployed on the first day of operations.
The billionaire also reiterated at the earnings call that he would scale back on his DOGE duties to focus on Tesla, which led to analysts like <a href="https://www.benzinga.com/25/04/44945402/wedbushs-dan-ives-raises-teslas-price-target-to-350-as-musk-promises-to-significantly-reduce-doge-time">Dan Ives setting high price targets</a> on Tesla Stock, as well as the stock itself surging in value.
However, Tesla has been grappling with its fair share of problems, including <a href="https://www.benzinga.com/tech/25/04/44857987/tesla-experiences-151-decline-in-new-vehicle-registrations-in-california-report">declining sales figures </a>in the U.S. <a href="https://www.benzinga.com/25/04/44975755/tesla-sales-decline-28-in-europe-as-ev-car-market-experiences-growth-report">as well as Europe</a>, and a 71% YoY profit plunge for Q1 2025, which showcases what was a difficult quarter for the EV giant. Tesla owners in the U.S. are also battling declining used car values as well as rising insurance premiums amid bouts of vandalism.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="205" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA-1024x205.jpg" alt="" class="wp-image-892178" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA-1024x205.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA-300x60.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA-768x154.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA-1536x307.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29031459/TSLA.jpg 1646w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
TSLA scores well on Momentum and Quality metrics, and has a satisfactory Growth score. However, the stock scores poorly in Value. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge</a> today!
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/04/45002938/tesla-bull-gary-black-says-robotaxi-experiment-in-austin-with-10-20-cars-does-not-warrant-billions-in-valuation-potential">Tesla Bull Gary Black Says Robotaxi &#8216;Experiment&#8217; In Austin With &#8217;10-20&#8242; Cars Does Not Warrant Billions In Valuation Potential</a></li>
</ul>
Image Via Shutterstock

Insider Trades

Tech

ABNB

TSLA

Airbnb Billionaire Joe Gebbia Buys Over $1 Million Worth Of TSLA Stock Ahead Of Elon Musk's Robotaxi Launch In June

Press Releases

Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer's Disease Publication of the Company's Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findings

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Acumen Pharmaceuticals to Present During International Conference on Alzheimer's and Parkinson's Diseases 2025 and American Academy of Neurology Annual Meeting

Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer's

Acumen Pharmaceuticals Announces Topline Results from Phase 1 Study of Subcutaneous Formulation of Sabirnetug in Healthy Volunteers

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Acumen Pharmaceuticals Completes Enrollment of ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer's Disease

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2024 and Business Highlights

Management

Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

Comments

Acumen Pharmaceuticals

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL